Uptravi

Made by

• Nippon Shinyaku

Active Ingredient

Selexipag

Prospectus

Approval date

2016/9/28

Treats

• Pulmonary arterial hypertension

Dosages

• Uptravi Tablets - 1430.7円／錠

• Uptravi Tablets - 2857.9円／錠